These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


119 related items for PubMed ID: 10371030

  • 1. Preparation and biological evaluation of 6/7-trifluoromethyl(nitro)-, 6,7-difluoro-3-alkyl (aryl)-substituted-quinoxalin-2-ones. Part 3.
    Sanna P, Carta A, Loriga M, Zanetti S, Sechi L.
    Farmaco; 1999 Mar 31; 54(3):169-77. PubMed ID: 10371030
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and evaluation for biological activity of 3-alkyl and 3-halogenoalkyl-quinoxalin-2-ones variously substituted. Part 4.
    Carta A, Sanna P, Loriga M, Setzu MG, La CP, Loddo R.
    Farmaco; 2002 Jan 31; 57(1):19-25. PubMed ID: 11902641
    [Abstract] [Full Text] [Related]

  • 3. Synthesis of 3,6,7-substituted-quinoxalin-2-ones for evaluation of antimicrobial and anticancer activity. Part 2.
    Sanna P, Carta A, Loriga M, Zanetti S, Sechi L.
    Farmaco; 1999 Mar 31; 54(3):161-8. PubMed ID: 10371029
    [Abstract] [Full Text] [Related]

  • 4. Quinoxalin-2-ones. Part 5. Synthesis and antimicrobial evaluation of 3-alkyl-, 3-halomethyl- and 3-carboxyethylquinoxaline-2-ones variously substituted on the benzo-moiety.
    Carta A, Loriga M, Zanetti S, Sechi LA.
    Farmaco; 2003 Dec 31; 58(12):1251-5. PubMed ID: 14630235
    [Abstract] [Full Text] [Related]

  • 5. Novel functionalized pyrido[2,3-g]quinoxalinones as antibacterial, antifungal and anticancer agents.
    Carta A, Sanna P, Gherardini L, Usai D, Zanetti S.
    Farmaco; 2001 Dec 31; 56(12):933-8. PubMed ID: 11829113
    [Abstract] [Full Text] [Related]

  • 6. Novel substituted quinoxaline 1,4-dioxides with in vitro antimycobacterial and anticandida activity.
    Carta A, Paglietti G, Rahbar Nikookar ME, Sanna P, Sechi L, Zanetti S.
    Eur J Med Chem; 2002 May 31; 37(5):355-66. PubMed ID: 12008050
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and Antimicrobial Activity of Some New Substituted Quinoxalines.
    El-Atawy MA, Hamed EA, Alhadi M, Omar AZ.
    Molecules; 2019 Nov 19; 24(22):. PubMed ID: 31752396
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and biological evaluation of some new amide moiety bearing quinoxaline derivatives as antimicrobial agents.
    Abu Mohsen U, Yurttaş L, Acar U, Özkay Y, Kaplacikli ZA, Karaca Gencer H, Cantürk Z.
    Drug Res (Stuttg); 2015 May 19; 65(5):266-71. PubMed ID: 24918343
    [Abstract] [Full Text] [Related]

  • 9. Quinoxaline chemistry. Part 8. 2-[Anilino]-3-[carboxy]-6(7)-substituted quinoxalines as non classical antifolate agents. Synthesis and evaluation of in vitro anticancer, anti-HIV and antifungal activity.
    Loriga M, Moro P, Sanna P, Paglietti G, Zanetti S.
    Farmaco; 1997 May 19; 52(8-9):531-7. PubMed ID: 9507661
    [Abstract] [Full Text] [Related]

  • 10. Synthesis of some new quinoxalines and 1,2,4-triazolo[4,3-a]-quinoxalines for evaluation of in vitro antitumor and antimicrobial activities.
    El-Hawash SA, Habib NS, Kassem MA.
    Arch Pharm (Weinheim); 2006 Oct 19; 339(10):564-71. PubMed ID: 17009301
    [Abstract] [Full Text] [Related]

  • 11. Quinoxaline derivatives. Part II: Synthesis and antimicrobial testing of 1,2,4-triazolo[4,3-a]quinoxalines, 1,2,4-triazino[4,3-a]quinoxalines and 2-pyrazolylquinoxalines.
    el-Hawash SA, Habib NS, Fanaki NH.
    Pharmazie; 1999 Nov 19; 54(11):808-13. PubMed ID: 10603606
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and in vitro-anticancer and antimicrobial evaluation of some novel quinoxalines derived from 3-phenylquinoxaline-2(1H)-thione.
    El-Hawash SA, Wahab AE.
    Arch Pharm (Weinheim); 2006 Aug 19; 339(8):437-47. PubMed ID: 16881038
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, anti-mycobacterial, anti-trichomonas and anti-candida in vitro activities of 2-substituted-6,7-difluoro-3-methylquinoxaline 1,4-dioxides.
    Carta A, Loriga M, Paglietti G, Mattana A, Fiori PL, Mollicotti P, Sechi L, Zanetti S.
    Eur J Med Chem; 2004 Feb 19; 39(2):195-203. PubMed ID: 14987828
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and antimicrobial testing of thiazolinyl-, thiazolidinonyl-quinoxalines and 1,2,4-triazolo[4,3-a]quinoxalines.
    Habib NS, el-Hawash SA.
    Pharmazie; 1997 Aug 19; 52(8):594-8. PubMed ID: 9292917
    [Abstract] [Full Text] [Related]

  • 15. Synthesis of substituted 2-ethoxycarbonyl- and 2-carboxyquinoxalin-3-ones for evaluation of antimicrobial and anticancer activity.
    Sanna P, Carta A, Loriga M, Zanetti S, Sechi L.
    Farmaco; 1998 Jul 30; 53(7):455-61. PubMed ID: 9836457
    [Abstract] [Full Text] [Related]

  • 16. Synthesis of certain substituted quinoxalines as antimicrobial agents (Part II).
    Badran MM, Abouzid KA, Hussein MH.
    Arch Pharm Res; 2003 Feb 30; 26(2):107-13. PubMed ID: 12643584
    [Abstract] [Full Text] [Related]

  • 17. Microwave assisted synthesis and antimicrobial activity of 2-quinoxalinone-3-hydrazone derivatives.
    Ajani OO, Obafemi CA, Nwinyi OC, Akinpelu DA.
    Bioorg Med Chem; 2010 Jan 01; 18(1):214-21. PubMed ID: 19948407
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo assessment of newer quinoxaline-oxadiazole hybrids as antimicrobial and antiprotozoal agents.
    Patel NB, Patel JN, Purohit AC, Patel VM, Rajani DP, Moo-Puc R, Lopez-Cedillo JC, Nogueda-Torres B, Rivera G.
    Int J Antimicrob Agents; 2017 Sep 01; 50(3):413-418. PubMed ID: 28687457
    [Abstract] [Full Text] [Related]

  • 19. Studies on furan derivatives. X. Preparation of 2-substituted 3-(5-nitro-2-furyl)guinoxaline 1,4-dioxides and determination of their antibacterial activity.
    Tanaka A, Usui T.
    Chem Pharm Bull (Tokyo); 1981 Jan 01; 29(1):110-5. PubMed ID: 7261188
    [No Abstract] [Full Text] [Related]

  • 20. Synthesis and antimicrobial activity of certain novel quinoxalines.
    Refaat HM, Moneer AA, Khalil OM.
    Arch Pharm Res; 2004 Nov 01; 27(11):1093-8. PubMed ID: 15595408
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.